<DOC>
	<DOCNO>NCT00241150</DOCNO>
	<brief_summary>A STUDY ON WHETHER AN ANTIHYPERTENSIVE MEDICATION PREVENTS DAMAGE TO WALLS OF VEINS IN FEMALE PATIENTS WITH THE METABOLIC SYNDROME ( OVERWEIGHT AND OTHER DISORDERS ) .</brief_summary>
	<brief_title>Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan ( 320 Mg ) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion : Subjects must meet follow inclusion criterion Visit 1 , Visit 2 Visit 3 . Inclusion criterion Group A ( overweight postmenopausal female highnormal blood pressure/ mild Stage I hypertension ) 1 . Nonsmoking female outpatient diagnose postmenopausal base age ( 48 65 year ) selfreported absence menstrual period least one year . 2 . Mean blood pressure 130 149 mm Hg systolic and/or 85 94 mm Hg diastolic â€¢ When systolic blood pressure diastolic blood pressure fall different category ( high normal versus mild stage I hypertension ) , high category select classify group subject . 3 . Body mass index great equal 26 less equal 41 kg/m2 4 . Subjects agree alter diet exercise routine study comply study specific restriction 24 hour prior next schedule study visit 5 . Subjects read , sign receive copy inform consent form prior initiation study procedure agree participate aspect study 1 . Nonsmoking female outpatient diagnose postmenopausal base age ( 48 65 year ) selfreported absence menstrual period least one year . 2 . Mean blood pressure 90 129 mm Hg systolic and/or 50 84 mm Hg diastolic . 3 . Body mass index great equal 26 less equal 41 kg/m2</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>valsartan</keyword>
	<keyword>hypertension</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>endothelial function</keyword>
</DOC>